NO981688D0 - Chirale metylfenyloksazolidinoner - Google Patents
Chirale metylfenyloksazolidinonerInfo
- Publication number
- NO981688D0 NO981688D0 NO981688A NO981688A NO981688D0 NO 981688 D0 NO981688 D0 NO 981688D0 NO 981688 A NO981688 A NO 981688A NO 981688 A NO981688 A NO 981688A NO 981688 D0 NO981688 D0 NO 981688D0
- Authority
- NO
- Norway
- Prior art keywords
- methylphenyloxazolidinones
- chiral
- production
- relates
- pharmaceutical agents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19540475A DE19540475A1 (de) | 1995-10-20 | 1995-10-20 | Chirale Methylphenyloxazolidinone |
PCT/DE1996/000259 WO1997015561A1 (de) | 1995-10-20 | 1996-02-09 | Chirale methylphenyloxazolidinone |
Publications (3)
Publication Number | Publication Date |
---|---|
NO981688D0 true NO981688D0 (no) | 1998-04-15 |
NO981688L NO981688L (no) | 1998-04-15 |
NO310772B1 NO310772B1 (no) | 2001-08-27 |
Family
ID=7776217
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19981688A NO310772B1 (no) | 1995-10-20 | 1998-04-15 | (R)-(-)-metylfenyloksazolidinon-derivater, fremgangsmåte for fremstilling derav, og anvendelse av disse for fremstilling av etlegemiddel |
Country Status (25)
Country | Link |
---|---|
US (1) | US6025376A (no) |
EP (1) | EP0859766B1 (no) |
JP (1) | JPH11513693A (no) |
KR (1) | KR100417359B1 (no) |
CN (1) | CN1077103C (no) |
AT (1) | ATE201203T1 (no) |
AU (1) | AU715344B2 (no) |
CZ (1) | CZ292167B6 (no) |
DE (2) | DE19540475A1 (no) |
DK (1) | DK0859766T3 (no) |
ES (1) | ES2158284T3 (no) |
FI (1) | FI980862A0 (no) |
GR (1) | GR3036305T3 (no) |
HK (1) | HK1015788A1 (no) |
HU (1) | HUP9802630A3 (no) |
IL (1) | IL117091A (no) |
NO (1) | NO310772B1 (no) |
NZ (1) | NZ301645A (no) |
PL (1) | PL185526B1 (no) |
PT (1) | PT859766E (no) |
RU (1) | RU2156243C2 (no) |
SK (1) | SK282653B6 (no) |
TR (1) | TR199800679T2 (no) |
WO (1) | WO1997015561A1 (no) |
ZA (1) | ZA961074B (no) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999009965A2 (en) * | 1997-08-21 | 1999-03-04 | Takeda Chemical Industries, Ltd. | Anti-inflammatory agent |
DE19928312A1 (de) * | 1999-06-16 | 2000-12-21 | Schering Ag | Arzneimittelzubereitung mit verzögerter Wirkstoffabgabe |
US6808902B1 (en) | 1999-11-12 | 2004-10-26 | Amgen Inc. | Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
EP1216700A1 (de) * | 2000-12-21 | 2002-06-26 | Schering Aktiengesellschaft | Transdermalsysteme (TDS) enthaltend (R)-(-)-Methylphenyloxazolidinon-Derivate, Inhibitoren der Phosphodiesterase IV |
GB0111872D0 (en) * | 2001-05-15 | 2001-07-04 | Northwick Park Inst For Medica | Therapeutic agents and methods |
EP1414517A4 (en) * | 2001-06-26 | 2008-02-06 | Photomed Technologies Inc | MULTIPLE WAVELENGTH ILLUMINATOR |
PT2087908T (pt) | 2001-06-26 | 2018-07-16 | Amgen Inc | Anticorpos contra opgl |
US20080026984A1 (en) * | 2002-02-04 | 2008-01-31 | Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
RU2004126950A (ru) * | 2002-02-04 | 2005-06-27 | АЛФАМА-Инвестигасау и Дезенволвименту де Продутош Фармасеутикуш Лда. (PT) | Использование выделяющих co соединений при изготовлении лекарственного средства для лечения воспалительных заболеваний |
US6962940B2 (en) | 2002-03-20 | 2005-11-08 | Celgene Corporation | (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
ES2211344B1 (es) * | 2002-12-26 | 2005-10-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
JP2006517191A (ja) * | 2002-12-30 | 2006-07-20 | アムジエン・インコーポレーテツド | 共刺激因子を用いた併用療法 |
US20070207217A1 (en) * | 2003-02-03 | 2007-09-06 | Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda | Method for treating a mammal by administration of a compound having the ability to release CO |
WO2004098592A1 (ja) * | 2003-05-06 | 2004-11-18 | Senju Pharmaceutical Co. Ltd. | オキサゾリジノン誘導体含有組成物 |
ES2251866B1 (es) | 2004-06-18 | 2007-06-16 | Laboratorios Almirall S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
ES2251867B1 (es) * | 2004-06-21 | 2007-06-16 | Laboratorios Almirall S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
US20110104186A1 (en) | 2004-06-24 | 2011-05-05 | Nicholas Valiante | Small molecule immunopotentiators and assays for their detection |
GB0601394D0 (en) | 2006-01-24 | 2006-03-01 | Hemocorm Ltd | Therapeutic delivery of carbon monoxide |
ES2320954B1 (es) * | 2007-03-02 | 2010-03-16 | Laboratorio Almirall S.A. | Nuevo procedimiento de preparacion de 3-metil-4-fenilisoxazolo (3,4-d)iridazin-7(6h)-ona. |
PT2699242T (pt) | 2011-04-19 | 2018-01-22 | Alfama Inc | Moléculas de libertação de monóxido de carbono e utilizações das mesmas |
EP2734235B1 (en) | 2011-07-21 | 2017-03-22 | Alfama, Inc. | Ruthenium carbon monoxide releasing molecules and uses thereof |
US11141410B2 (en) | 2015-12-16 | 2021-10-12 | Merck Sharp & Dohme Corp | Oxazolidinones as taro inhibitors |
US10736905B1 (en) | 2016-09-09 | 2020-08-11 | Shahin Fatholahi | Nefopam dosage forms and methods of treatment |
US10736874B1 (en) | 2017-09-08 | 2020-08-11 | Shahin Fatholahi | Methods for treating pain associated with sickle cell disease |
US11446311B2 (en) | 2017-09-08 | 2022-09-20 | Shahin Fatholahi | Methods for treating pain associated with sickle cell disease |
US20210145838A1 (en) * | 2018-04-05 | 2021-05-20 | Universiteit Hasselt | Selective pde4d inhibitors against demyelinating diseases |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2413935A1 (de) * | 1974-03-20 | 1975-10-16 | Schering Ag | 4-(polyalkoxy-phenyl)-2-pyrrolidone |
DE2541855A1 (de) * | 1975-09-18 | 1977-03-31 | Schering Ag | 4-(polyalkoxy-phenyl)-2-pyrrolidone ii |
FR2358155A1 (fr) * | 1976-07-15 | 1978-02-10 | Lapinet Eugene | Composition pour le traitement et la prevention de l'irritation et de l'inflammation de la peau, de l'oeil et des muqueuses |
DE2655369A1 (de) * | 1976-12-03 | 1978-06-08 | Schering Ag | 5-(subst. phenyl)-oxazolidinone und deren schwefelanaloga sowie verfahren zu deren herstellung |
US5783591A (en) * | 1984-10-19 | 1998-07-21 | Schering Aktiengesellschaft | Administration of oxazolidinone and pyrolidinone compounds for the treatment of inflammation |
DE3438839A1 (de) * | 1984-10-19 | 1986-04-24 | Schering AG, 1000 Berlin und 4709 Bergkamen | Pharmazeutische praeparate |
DE3639225A1 (de) * | 1986-11-14 | 1988-05-19 | Schering Ag | Verwendung von 5-(subst. phenyl)-oxazolidinonderiaten als psychopharmaka |
WO1991000092A1 (en) * | 1989-06-13 | 1991-01-10 | Smithkline Beecham Corporation | Inhibition of interleukin-1 and tumor necrosis factor production by monocytes and/or macrophages |
AU8292091A (en) * | 1990-08-03 | 1992-03-02 | Smithkline Beecham Corporation | Tnf inhibitors |
PT100441A (pt) * | 1991-05-02 | 1993-09-30 | Smithkline Beecham Corp | Pirrolidinonas, seu processo de preparacao, composicoes farmaceuticas que as contem e uso |
US5227369A (en) * | 1991-07-11 | 1993-07-13 | The Regents Of The University Of California | Compositions and methods for inhibiting leukocyte adhesion to cns myelin |
CA2117547A1 (en) * | 1992-02-24 | 1993-09-02 | Michiko Watanabe | Ice nucleus-forming bacterium, process for cultivation of the same, ice nucleus-forming substance containing the same, and uses of said substance |
GB9204808D0 (en) * | 1992-03-04 | 1992-04-15 | Rhone Poulenc Rorer Ltd | Novel compositions of matter |
US5264437A (en) * | 1992-03-20 | 1993-11-23 | Syntex (U.S.A.) Inc. | Optionally substituted pyrido[2,3-d]pyridine-2,4(1H,3H)-diones and pyrido[2,]pyrimidine-2(1H,3H)-ones |
US5672622A (en) * | 1994-04-21 | 1997-09-30 | Berlex Laboratories, Inc. | Treatment of multiple sclerosis |
-
1995
- 1995-10-20 DE DE19540475A patent/DE19540475A1/de not_active Withdrawn
-
1996
- 1996-02-09 CN CN96197740A patent/CN1077103C/zh not_active Expired - Fee Related
- 1996-02-09 KR KR10-1998-0702843A patent/KR100417359B1/ko not_active IP Right Cessation
- 1996-02-09 ES ES96902871T patent/ES2158284T3/es not_active Expired - Lifetime
- 1996-02-09 JP JP9516174A patent/JPH11513693A/ja not_active Ceased
- 1996-02-09 DE DE59606920T patent/DE59606920D1/de not_active Expired - Fee Related
- 1996-02-09 DK DK96902871T patent/DK0859766T3/da active
- 1996-02-09 ZA ZA9601074A patent/ZA961074B/xx unknown
- 1996-02-09 NZ NZ301645A patent/NZ301645A/xx unknown
- 1996-02-09 WO PCT/DE1996/000259 patent/WO1997015561A1/de active IP Right Grant
- 1996-02-09 TR TR1998/00679T patent/TR199800679T2/xx unknown
- 1996-02-09 EP EP96902871A patent/EP0859766B1/de not_active Expired - Lifetime
- 1996-02-09 IL IL11709196A patent/IL117091A/xx not_active IP Right Cessation
- 1996-02-09 PT PT96902871T patent/PT859766E/pt unknown
- 1996-02-09 AT AT96902871T patent/ATE201203T1/de not_active IP Right Cessation
- 1996-02-09 RU RU98109898/04A patent/RU2156243C2/ru not_active IP Right Cessation
- 1996-02-09 CZ CZ19981201A patent/CZ292167B6/cs not_active IP Right Cessation
- 1996-02-09 PL PL96326322A patent/PL185526B1/pl not_active IP Right Cessation
- 1996-02-09 AU AU47123/96A patent/AU715344B2/en not_active Ceased
- 1996-02-09 SK SK495-98A patent/SK282653B6/sk unknown
- 1996-02-09 HU HU9802630A patent/HUP9802630A3/hu unknown
- 1996-08-02 US US08/691,651 patent/US6025376A/en not_active Expired - Fee Related
-
1998
- 1998-04-15 NO NO19981688A patent/NO310772B1/no unknown
- 1998-04-17 FI FI980862A patent/FI980862A0/fi unknown
-
1999
- 1999-03-12 HK HK99101010A patent/HK1015788A1/xx not_active IP Right Cessation
-
2001
- 2001-07-31 GR GR20010401155T patent/GR3036305T3/el not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE201203T1 (de) | Chirale methylphenyloxazolidinone | |
EE200000320A (et) | Uudsed ühendid | |
SE9704544D0 (sv) | Novel compounds | |
NO20000935L (no) | Fremgangsmåte for inhibering av komplementaktivering via den alternative reaksjonsvei | |
ZA965752B (en) | Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents. | |
KR960702830A (ko) | 방사선 보호제로서의 N-알킬티오 폴리아민 유도체(N-Alkylthio polyaine derivatives as radioprotective agents) | |
MX9705726A (es) | Amidas del acido alcoximinoacetico. | |
TR199800608A3 (tr) | Propanolamin türevleri, bunlarin üretim usulü. | |
YU63696A (sh) | Novi fenilamidin-derivati, postupci za njihovo pripremanje i njihova primena kao lekova | |
AU2895397A (en) | Novel substance library and supramolecular complexes prepared therewith | |
YU12000A (sh) | Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova | |
MX9706744A (es) | Proceso novedosos para preparar derivados de 2,3-dihidro-benzofuranol. | |
NO985462L (no) | Karbohydrat-derivater og fastfase-syntese derav | |
PT1246790E (pt) | Bases de mannich de 1- e 2-naftol substituido | |
ATE196292T1 (de) | Zwischenprodukte um 2-imidazolin-5onederivate herzustellen. | |
ATE242763T1 (de) | Methoximinophenylessigsäureamide | |
MY127328A (en) | 5-amino-1-pentene-3-ol substituted derivatives | |
PT796256E (pt) | Novos processos de preparacao da ranitidina | |
SE9704834D0 (sv) | New process | |
MY113450A (en) | Anellated b-carbolines | |
MX9700585A (es) | Derivados de n-alcoxi-amidina y su empleo como agentes pesticidas. | |
SE9503757D0 (sv) | Process for the production of ranitidine | |
MX9606264A (es) | Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol como sustancias farmacologicas activas. | |
MX9710530A (es) | Derivados de benzo (a) quinolina. | |
KR970028045U (ko) | 목업 제작용 둥근톱기계 |